These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23759653)

  • 21. Heterogenic molecular basis for loss of ABL1-BCR transcription: deletions in der(9)t(9;22) and variants of standard t(9;22) in BCR-ABL1-positive chronic myeloid leukemia.
    Loncarevic IF; Römer J; Starke H; Heller A; Bleck C; Ziegler M; Fiedler W; Liehr T; Clement JH; Claussen U
    Genes Chromosomes Cancer; 2002 Jun; 34(2):193-200. PubMed ID: 11979553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Ph-negative chronic myeloid leukemia with a complex BCR/ABL rearrangement and a t(6;9)(p21;q34.1).
    Todorić-Zivanović B; Marisavljević D; Surace C; Cemerikić V; Marković O; Krtolica K; Tatomirović Z; Cikota B; Magić Z; Rocchi M
    Cancer Genet Cytogenet; 2006 Apr; 166(2):180-5. PubMed ID: 16631477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uncommon karyotypic abnormality, t(11;19)(q23;p13.3), in a patient with blastic phase of chronic myeloid leukemia.
    Suzuki K; Sugawara T; Kowata S; Utsugizawa T; Ito S; Murai K; Ishida Y
    Cancer Genet Cytogenet; 2004 Apr; 150(2):159-63. PubMed ID: 15066325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Karyotype changes during long-term targeted therapy of chronic myeloid leukemia with imatinib.
    Pieńkowska-Grela B; Rygier J; Woroniecka R; Grygalewicz B; Pastwińska A; Krawczyk P; Ceglerek B; Seferyńska I; Sikorska A; Konopka L
    Leuk Lymphoma; 2009 Jun; 50(6):952-65. PubMed ID: 19479611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a complex translocation [t(4;9;22)(p16;q34;q11)] in chronic myelogenous leukemia by fluorescence in situ hybridization technique.
    Gudi R; Elizalde A; Gogineni SK; Macera MJ; Badillo A; Verma RS
    Cancer Genet Cytogenet; 1996 Sep; 90(2):142-5. PubMed ID: 8830724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Additional rearrangements affecting the derivative chromosome 9 involved in the standard Philadelphia translocation after imatinib therapy in a patient with chronic myeloid leukemia.
    Wang HP; Chen ZM; Lou JY; Xu H; Yu YB; Jin J
    Cancer Genet Cytogenet; 2008 Apr; 182(1):63-4. PubMed ID: 18328955
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical, morphological, cytogenetic and molecular aspects of a series of Ph-negative chronic myeloid leukemias.
    Aurich J; Duchayne E; Huguet-Rigal F; Bauduer F; Navarro M; Perel Y; Pris J; Caballin MR; Dastugue N
    Hematol Cell Ther; 1998 Aug; 40(4):149-58. PubMed ID: 9766919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-wide high density single-nucleotide polymorphism array-based karyotyping improves detection of clonal aberrations including der(9) deletion, but does not predict treatment outcomes after imatinib therapy in chronic myeloid leukemia.
    Huh J; Jung CW; Kim JW; Kim HJ; Kim SH; Shin MG; Kim YK; Kim HJ; Suh JS; Moon JH; Sohn SK; Nam GH; Lee JE; Kim DH
    Ann Hematol; 2011 Nov; 90(11):1255-64. PubMed ID: 21384125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic myeloid leukemia with a rare variant BCR-ABL translocation: t(9;22;21)(q34;q11.2;q11.2).
    Takeuchi M; Katayama Y; Okamura A; Yamamoto K; Shimoyama M; Matsui T
    Cancer Genet Cytogenet; 2007 Nov; 179(1):85-7. PubMed ID: 17981222
    [No Abstract]   [Full Text] [Related]  

  • 30. Imatinib resistance in a novel translocation der(17)t(1;17)(q25;p13) with loss of TP53 but without BCR/ABL kinase domain mutation in chronic myelogenous leukemia.
    Yamamoto K; Yakushijin K; Nishikawa S; Minagawa K; Katayama Y; Shimoyama M; Matsui T
    Cancer Genet Cytogenet; 2008 May; 183(1):77-81. PubMed ID: 18474303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.
    Vefring HK; Gruber FX; Wee L; Hovland R; Hjorth-Hansen H; Gedde Dahl T; Meyer P
    Acta Haematol; 2009; 122(1):11-6. PubMed ID: 19641300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular characterization of a variant Ph1 translocation t(9;22;11) (q34;q11;q13) in chronic myelogenous leukemia (CML) reveals the translocation of the 3'-part of BCR gene to the chromosome band 11q13.
    Koduru PR; Goh JC; Pergolizzi RG; Lichtman SM; Broome JD
    Oncogene; 1993 Dec; 8(12):3239-47. PubMed ID: 8247527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of HLA Class I and Class II genes with bcr-abl transcripts in leukemia patients with t(9;22) (q34;q11).
    Mundhada S; Luthra R; Cano P
    BMC Cancer; 2004 Jun; 4():25. PubMed ID: 15202948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The tyrosine-kinase inhibitor imatinib induces long-term remission in a patient with chronic myelogenous leukemia with translocation t(4;22).
    Neumann F; Poelitz A; Hildebrandt B; Fenk R; Haas R; Royer-Pokora B; Germing U
    Leukemia; 2007 Apr; 21(4):836-7. PubMed ID: 17268524
    [No Abstract]   [Full Text] [Related]  

  • 35. A unique case of complex variant translocation of t(6;9;22)(p22;q34;q11.2), der(19) in a newly diagnosed patient with chronic myeloid leukemia.
    Ciftciler R; Saglam EA; Inanc A; Ozcebe O; Haznedaroglu IC
    Cancer Genet; 2019 Sep; 237():78-81. PubMed ID: 31447069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9) (p23;q34) translocation.
    Jadayel D; Calabrese G; Min T; van Rhee F; Swansbury GJ; Dyer MJ; Maitland J; Palka G; Catovsky D
    Leukemia; 1995 Jun; 9(6):981-7. PubMed ID: 7596189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular genetics in chronic myeloid leukemia with variant Ph translocation].
    Wu W; Li JY; Zhu Y; Qiu HR; Pan JL; Xu W; Chen LJ; Shen YF; Xue YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):470-3. PubMed ID: 17680547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukaemia cutis in atypical chronic myeloid leukaemia with a t(9;22) (p24;q11.2) leading to BCR-JAK2 fusion.
    Lane SW; Fairbairn DJ; McCarthy C; Nandini A; Perry-Keene J; Kennedy GA
    Br J Haematol; 2008 Aug; 142(4):503. PubMed ID: 18537978
    [No Abstract]   [Full Text] [Related]  

  • 39. A complex translocation t(5;9;22) in Philadelphia cells involving the short arm of chromosome 5 in a case of chronic myelogenous leukemia.
    Al-Achkar W; Wafa A; Nweder MS
    J Exp Clin Cancer Res; 2007 Sep; 26(3):411-5. PubMed ID: 17987804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The first case of six-way complex translocation of t(4;7;9;22;8;14) in a patient with chronic myeloid leukemia.
    Bi X; Li C; Shang M; Han B; Li H; Sun L; Lin Y; Yang S
    J Hematop; 2024 Jun; 17(2):97-101. PubMed ID: 38492169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.